Alvotech is trading at ISK 700.00, down 4.37%, with the cause of the decline unidentified in the October 1, 2026 price context. - The latest session ended September 30; coverage described the shares as down and reported no clear company-specific catalyst. - Searches found no new Alvotech announcement for October 1. - Broader market evidence is mixed and does not clearly explain the decline; earlier analyst and FDA-related news also does not account for this move.